IGC Pharma, Inc.

IGC

Exchange: NYSE
Industry: Pharmaceutical Preparations
SEC CIK: 0001326205

SEC filings (opens in a new tab)

No open-market purchases or sales by IGC Pharma, Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $1.41M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding IGC Pharma, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026 All holders in Q1 2026

13F holders of IGC: Q1 2026 compared with Q2 2026
Measure	Q1 2026	Of which not filed for Q2 2026	Q2 2026	Change
Holders	35	2	36	+3
Shares	4.33M	6.00K	5.19M	+867.3K (+20.0%)
Value	$1.14M	$1.58K	$1.41M	+$275.0K (+24.2%)

2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (7)

Institutions that held IGC Pharma, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to IGC in Q2 2026
Institution	Shares	Value	% of portfolio
AdvisorShares Investments LLC	678,480	$184.5K	0.02%
Citadel Advisors LLC	437,317	$119.0K	0.00%
Jane Street Group, LLC	62,610	$17.0K	0.00%
Citigroup Inc	46,043	$12.5K	0.00%
Burnham & Co LLC	5,000	$1.36K	0.00%
Rockefeller Capital Management L.P.	1,000	$272	0.00%
Barclays PLC	721	$196	0.00%

Sold out (4)

Institutions that held IGC Pharma, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of IGC in Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Virtu Financial LLC	23,233	$6.00K
T3 Companies, LLC	20,000	$5.26K
HighTower Advisors, LLC	10,000	$2.63K
Schneider Downs Wealth Management Advisors, LP	10,000	$2.63K

Not filed for Q2 2026 yet (2)

Institutions that held IGC Pharma, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IGC in Q1 2026 that haven't filed for Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Trask Adam Roland	5,000	$1.31K
CWM, LLC	1,000	$263